Bausch + lomb corporation files financial statements for the first quarter of 2022

Vaughan, on , may 16, 2022 /prnewswire/ -- bausch + lomb corporation (nyse/tsx: blco) ("bausch + lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, has today filed its financial statements for the quarter ended march 31, 2022, in accordance with applicable canadian securities laws. the company intends to file its quarterly report on form 10-q for the quarterly period ended march 31, 2022 on or before june 20, 2022 (being the first business day that is 45 days from the date of effectiveness of bausch + lomb's registration statement on form s-1, as amended, filed in connection with the company's recent initial public offering) in compliance with the u.s. securities and exchange commission rules.
BLCO Ratings Summary
BLCO Quant Ranking